RT Journal Article
SR Electronic
T1 Innate immune deficiencies in patients with COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.29.21254560
DO 10.1101/2021.03.29.21254560
A1 Peyneau, Marine
A1 Granger, Vanessa
A1 Wicky, Paul-Henri
A1 Khelifi-Touhami, Dounia
A1 Timsit, Jean-François
A1 Lescure, François-Xavier
A1 Yazdanpanah, Yazdan
A1 Tran-Dihn, Alexy
A1 Montravers, Philippe
A1 Monteiro, Renato C.
A1 Chollet-Martin, Sylvie
A1 Hurtado-Nedelec, Margarita
A1 de Chaisemartin, Luc
YR 2021
UL http://medrxiv.org/content/early/2021/03/31/2021.03.29.21254560.abstract
AB COVID-19 can cause acute respiratory distress syndrome (ARDS), leading to death in a significant number of individuals. Evidence of a strong role of the innate immune system is accumulating, but the precise cells and mechanism involved remain unclear. In this study, we investigated the links between circulating innate phagocyte phenotype and functions and severity in COVID-19 patients. Eighty-four consecutive patients were included, 44 of which were in intensive care units (ICU). We performed an in-depth phenotyping of neutrophil and monocyte subpopulations and measured soluble activation markers in plasma. Additionally, myeloid cell functions (phagocytosis, oxidative burst, and NETosis) were evaluated on fresh cells from patients. Resulting parameters were linked to disease severity and prognosis. Both ICU and non-ICU patients had circulating neutrophils and monocytes with an activated phenotype, as well as elevated concentrations of soluble activation markers (calprotectin, myeloperoxidase, neutrophil extracellular traps, MMP9, sCD14) in their plasma. ICU patients were characterized by increased CD10low CD13low immature neutrophils, LOX-1+ and CCR5+ immunosuppressive neutrophils, and HLA-DRlow CD14low downregulated monocytes. Markers of immature and immunosuppressive neutrophils were strongly associated with severity and poor outcome. Moreover, neutrophils and monocytes of ICU patients had impaired antimicrobial functions, which correlated with organ dysfunction, severe infections, and mortality. Our study reveals a marked dysregulation of innate immunity in COVID-19 patients, which was correlated with severity and prognosis. Together, our results strongly argue in favor of a pivotal role of innate immunity in COVID-19 severe infections and pleads for targeted therapeutic options.One Sentence Summary Our study reveals a marked dysregulation of innate immunity in COVID-19 patients, which correlates with severity and prognosis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by the French National Research Agency (ANR) RA-COVID-19 V5 grant under the name COVINNATEAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by National Ethics committee CEEI/IRB under the number 20-715.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available upon reasonable request